  Bone pain typically occurs immediately following skeletal damage with
mechanical distortion or rupture of nociceptive fibres. The pain mechanism is
also associated with chronic pain conditions where the healing process is
impaired. Any load impacting on the area of the fractured bone will increase
the intraosseous pressure, consequently stimulating the nociceptive response,
necessitating rapid clinical intervention to relieve pain associated with the
bone damage and appropriate mitigation of any processes involved with the loss
of bone mass, muscle, mobility and, to prevent death. The following review has
examined the mechanisms of pain associated with trauma or cancer-related
skeletal damage focusing on new approaches for the development of innovative
therapeutic interventions. In particular, the current review highlights tissue
engineering approaches that offer considerable promise in the application of
functional biomimetic fabrication of bone and nerve tissues, resembling the
pathological micro-environment. The strategic combination of bone and nerve
tissue engineered models provides significant potential to develop a new class
of in vitro platforms, capable of replacing in vivo models and testing the
safety and efficacy of novel drug treatments aimed at the resolution of
bone-associated pain. To date, the field of bone pain research has centred on
animal models, with accompanying disparity within models often noted and a
paucity of data correlating to the human physiological response. This review
explores the evident gap in pain drug development research and suggests a step
change in approach to harness tissue engineering technologies to recapitulate
the complex pathophysiological environment of the damaged bone tissue enabling
evaluation of the associated pain-mimicking mechanism with, ultimately,
significant therapeutic potential therein for improved patient quality of life.
